Click here to get full coverage on CG Oncology (CGON): Assessing Valuation Following Analyst Coverage and Positive Phase 3 Trial Results - Yahoo Finance

CG Oncology (CGON): Assessing Valuation Following Analyst Coverage and Positive Phase 3 Trial Results  Yahoo Finance

CG Oncology (CGON): Assessing Valuation Following Analyst Coverage and Positive Phase 3 Trial Results - Yahoo Finance

Click here to get full coverage on Volatility clustering patterns for CGON - Earnings Miss & Weekly Breakout Stock Alerts - newser.com

Volatility clustering patterns for CGON - Earnings Miss & Weekly Breakout Stock Alerts  newser.com

Volatility clustering patterns for CGON - Earnings Miss & Weekly Breakout Stock Alerts - newser.com

Click here to get full coverage on Noteworthy Tuesday Option Activity: CGON, DECK, ARQT - Nasdaq

Noteworthy Tuesday Option Activity: CGON, DECK, ARQT  Nasdaq

Noteworthy Tuesday Option Activity: CGON, DECK, ARQT - Nasdaq

Click here to get full coverage on CG Oncology: Upgraded, Rising, But Should We Still Be Optimistic? (NASDAQ:CGON) - Seeking Alpha

CG Oncology: Upgraded, Rising, But Should We Still Be Optimistic? (NASDAQ:CGON)  Seeking Alpha

CG Oncology: Upgraded, Rising, But Should We Still Be Optimistic? (NASDAQ:CGON) - Seeking Alpha

Click here to get full coverage on CG Oncology (CGON) Gets Initiated With a Buy at Guggenheim - Yahoo Finance

CG Oncology (CGON) Gets Initiated With a Buy at Guggenheim  Yahoo Finance

CG Oncology (CGON) Gets Initiated With a Buy at Guggenheim - Yahoo Finance

Click here to get full coverage on What analyst consensus says on CGON stock - Insider Buying & Weekly Market Pulse Alerts - newser.com

What analyst consensus says on CGON stock - Insider Buying & Weekly Market Pulse Alerts  newser.com

What analyst consensus says on CGON stock - Insider Buying & Weekly Market Pulse Alerts - newser.com

Click here to get full coverage on Guggenheim Initiates Coverage of CG Oncology (CGON) with Buy Recommendation - Nasdaq

Guggenheim Initiates Coverage of CG Oncology (CGON) with Buy Recommendation  Nasdaq

Guggenheim Initiates Coverage of CG Oncology (CGON) with Buy Recommendation - Nasdaq

Click here to get full coverage on Guggenheim Initiates CG Oncology (CGON) Coverage with $90 PT, Highlights Bladder Cancer Therapeutic Cretostimogene - Yahoo Finance

Guggenheim Initiates CG Oncology (CGON) Coverage with $90 PT, Highlights Bladder Cancer Therapeutic Cretostimogene  Yahoo Finance

Guggenheim Initiates CG Oncology (CGON) Coverage with $90 PT, Highlights Bladder Cancer Therapeutic Cretostimogene - Yahoo Finance

Click here to get full coverage on How to track smart money flows in CGON - Weekly Trend Report & Intraday High Probability Setup Alerts - newser.com

How to track smart money flows in CGON - Weekly Trend Report & Intraday High Probability Setup Alerts  newser.com

How to track smart money flows in CGON - Weekly Trend Report & Intraday High Probability Setup Alerts - newser.com

Click here to get full coverage on CG Oncology (CGON) PT Raised to $79 by Morgan Stanley on Strong Clinical Pipeline for Bladder Cancer Treatment - Yahoo Finance

CG Oncology (CGON) PT Raised to $79 by Morgan Stanley on Strong Clinical Pipeline for Bladder Cancer Treatment  Yahoo Finance

CG Oncology (CGON) PT Raised to $79 by Morgan Stanley on Strong Clinical Pipeline for Bladder Cancer Treatment - Yahoo Finance

Click here to get full coverage on Volatility clustering patterns for CGON - 2025 EndofYear Setup & Free Expert Verified Stock Movement Alerts - newser.com

Volatility clustering patterns for CGON - 2025 EndofYear Setup & Free Expert Verified Stock Movement Alerts  newser.com

Volatility clustering patterns for CGON - 2025 EndofYear Setup & Free Expert Verified Stock Movement Alerts - newser.com

Click here to get full coverage on CG Oncology (CGON) Is Up 23.3% After 24-Month Complete Response Data in Phase 3 Bladder Cancer Study - Yahoo Finance

CG Oncology (CGON) Is Up 23.3% After 24-Month Complete Response Data in Phase 3 Bladder Cancer Study  Yahoo Finance

CG Oncology (CGON) Is Up 23.3% After 24-Month Complete Response Data in Phase 3 Bladder Cancer Study - Yahoo Finance

Click here to get full coverage on How to track smart money flows in CGON - Trade Analysis Summary & Comprehensive Market Scan Insights - newser.com

How to track smart money flows in CGON - Trade Analysis Summary & Comprehensive Market Scan Insights  newser.com

How to track smart money flows in CGON - Trade Analysis Summary & Comprehensive Market Scan Insights - newser.com

Click here to get full coverage on CG Oncology, Inc. (CGON) Moves 5.5% Higher: Will This Strength Last? - Yahoo Finance

CG Oncology, Inc. (CGON) Moves 5.5% Higher: Will This Strength Last?  Yahoo Finance

CG Oncology, Inc. (CGON) Moves 5.5% Higher: Will This Strength Last? - Yahoo Finance

Click here to get full coverage on What high frequency data says about CGON - Recession Risk & Trade Opportunity Analysis - newser.com

What high frequency data says about CGON - Recession Risk & Trade Opportunity Analysis  newser.com

What high frequency data says about CGON - Recession Risk & Trade Opportunity Analysis - newser.com

Click here to get full coverage on Volatility clustering patterns for CGON - July 2025 Recap & Advanced Technical Signal Analysis - newser.com

Volatility clustering patterns for CGON - July 2025 Recap & Advanced Technical Signal Analysis  newser.com

Volatility clustering patterns for CGON - July 2025 Recap & Advanced Technical Signal Analysis - newser.com

Click here to get full coverage on CG Oncology (CGON) Reports Promising Results In BOND-003 Trial - Yahoo Finance

CG Oncology (CGON) Reports Promising Results In BOND-003 Trial  Yahoo Finance

CG Oncology (CGON) Reports Promising Results In BOND-003 Trial - Yahoo Finance

Click here to get full coverage on CGON stock momentum explained - July 2025 Retail & Consistent Profit Trade Alerts - newser.com

CGON stock momentum explained - July 2025 Retail & Consistent Profit Trade Alerts  newser.com

CGON stock momentum explained - July 2025 Retail & Consistent Profit Trade Alerts - newser.com

Click here to get full coverage on CG Oncology, Inc. (CGON) Reports 75.5% Complete Response in Bladder Cancer Trial - Yahoo Finance

CG Oncology, Inc. (CGON) Reports 75.5% Complete Response in Bladder Cancer Trial  Yahoo Finance

CG Oncology, Inc. (CGON) Reports 75.5% Complete Response in Bladder Cancer Trial - Yahoo Finance

Click here to get full coverage on CGON stock momentum explained - Portfolio Performance Report & Verified Chart Pattern Signals - newser.com

CGON stock momentum explained - Portfolio Performance Report & Verified Chart Pattern Signals  newser.com

CGON stock momentum explained - Portfolio Performance Report & Verified Chart Pattern Signals - newser.com

Click here to get full coverage on CG Oncology (CGON): Assessing Valuation Following Phase 3 Trial Progress and Upbeat Analyst Outlook - simplywall.st

CG Oncology (CGON): Assessing Valuation Following Phase 3 Trial Progress and Upbeat Analyst Outlook  simplywall.st

CG Oncology (CGON): Assessing Valuation Following Phase 3 Trial Progress and Upbeat Analyst Outlook - simplywall.st

Click here to get full coverage on $CGON stock is up 10% today. Here's what we see in our data. - Quiver Quantitative

$CGON stock is up 10% today. Here's what we see in our data.  Quiver Quantitative

$CGON stock is up 10% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Why CG Oncology, Inc. (CGON) Surged on Monday - Yahoo Finance

Why CG Oncology, Inc. (CGON) Surged on Monday  Yahoo Finance

Why CG Oncology, Inc. (CGON) Surged on Monday - Yahoo Finance

Click here to get full coverage on What analyst consensus says on CGON stock - 2025 Winners & Losers & Capital Efficiency Focused Ideas - newser.com

What analyst consensus says on CGON stock - 2025 Winners & Losers & Capital Efficiency Focused Ideas  newser.com

What analyst consensus says on CGON stock - 2025 Winners & Losers & Capital Efficiency Focused Ideas - newser.com

Click here to get full coverage on CG Oncology (CGON) Is Up 5.3% After Advancing BOND-003 Trial and Analyst Upgrades Is the Momentum Sustainable? - simplywall.st

CG Oncology (CGON) Is Up 5.3% After Advancing BOND-003 Trial and Analyst Upgrades Is the Momentum Sustainable?  simplywall.st

CG Oncology (CGON) Is Up 5.3% After Advancing BOND-003 Trial and Analyst Upgrades Is the Momentum Sustainable? - simplywall.st

Click here to get full coverage on CG Oncology stock initiated Buy at Guggenheim (CGON:NASDAQ) - Seeking Alpha

CG Oncology stock initiated Buy at Guggenheim (CGON:NASDAQ)  Seeking Alpha

CG Oncology stock initiated Buy at Guggenheim (CGON:NASDAQ) - Seeking Alpha

Click here to get full coverage on Liu Brian Guan-Chyun buys CG Oncology (CGON) shares worth $49.9m - Investing.com

Liu Brian Guan-Chyun buys CG Oncology (CGON) shares worth $49.9m  Investing.com

Liu Brian Guan-Chyun buys CG Oncology (CGON) shares worth $49.9m - Investing.com

Click here to get full coverage on CG Oncology, Inc. (CGON) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - Yahoo Finance

CG Oncology, Inc. (CGON) May Report Negative Earnings: Know the Trend Ahead of Q1 Release  Yahoo Finance

CG Oncology, Inc. (CGON) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - Yahoo Finance

Click here to get full coverage on H.C. Wainwright Reiterates a Buy on CG Oncology (CGON), Keeps the PT - Yahoo Finance

H.C. Wainwright Reiterates a Buy on CG Oncology (CGON), Keeps the PT  Yahoo Finance

H.C. Wainwright Reiterates a Buy on CG Oncology (CGON), Keeps the PT - Yahoo Finance

Click here to get full coverage on What analyst consensus says on CGON stock - 2025 AllTime Highs & Verified Momentum Stock Alerts - newser.com

What analyst consensus says on CGON stock - 2025 AllTime Highs & Verified Momentum Stock Alerts  newser.com

What analyst consensus says on CGON stock - 2025 AllTime Highs & Verified Momentum Stock Alerts - newser.com

Click here to get full coverage on CG Oncology (NASDAQ:CGON) Sees Unusually-High Trading Volume - Time to Buy? - MarketBeat

CG Oncology (NASDAQ:CGON) Sees Unusually-High Trading Volume - Time to Buy?  MarketBeat

CG Oncology (NASDAQ:CGON) Sees Unusually-High Trading Volume - Time to Buy? - MarketBeat

Click here to get full coverage on CGON stock momentum explained - 2025 Market Outlook & Daily Volume Surge Trade Alerts - newser.com

CGON stock momentum explained - 2025 Market Outlook & Daily Volume Surge Trade Alerts  newser.com

CGON stock momentum explained - 2025 Market Outlook & Daily Volume Surge Trade Alerts - newser.com

Click here to get full coverage on How to recover losses in CGON stock - July 2025 Summary & Risk Controlled Daily Plans - newser.com

How to recover losses in CGON stock - July 2025 Summary & Risk Controlled Daily Plans  newser.com

How to recover losses in CGON stock - July 2025 Summary & Risk Controlled Daily Plans - newser.com

Click here to get full coverage on How to recover losses in CGON stock - July 2025 Decliners & Weekly High Potential Stock Alerts - newser.com

How to recover losses in CGON stock - July 2025 Decliners & Weekly High Potential Stock Alerts  newser.com

How to recover losses in CGON stock - July 2025 Decliners & Weekly High Potential Stock Alerts - newser.com

Click here to get full coverage on After-Hours Rally Lifts PALI, HCTI, NTRB, KPTI, EDIT, And CGON On Mixed News And Strategic Moves - Nasdaq

After-Hours Rally Lifts PALI, HCTI, NTRB, KPTI, EDIT, And CGON On Mixed News And Strategic Moves  Nasdaq

After-Hours Rally Lifts PALI, HCTI, NTRB, KPTI, EDIT, And CGON On Mixed News And Strategic Moves - Nasdaq

Click here to get full coverage on Why Cg Oncology Stock Rocketed 7% Higher Today - The Motley Fool

Why Cg Oncology Stock Rocketed 7% Higher Today  The Motley Fool

Why Cg Oncology Stock Rocketed 7% Higher Today - The Motley Fool

Click here to get full coverage on Insider Sale: Director at $CGON Sells 1,000 Shares - Quiver Quantitative

Insider Sale: Director at $CGON Sells 1,000 Shares  Quiver Quantitative

Insider Sale: Director at $CGON Sells 1,000 Shares - Quiver Quantitative

Click here to get full coverage on How CGON stock benefits from tech adoption - July 2025 Analyst Calls & Verified Technical Trade Signals - fcp.pa.gov.br

How CGON stock benefits from tech adoption - July 2025 Analyst Calls & Verified Technical Trade Signals  fcp.pa.gov.br

How CGON stock benefits from tech adoption - July 2025 Analyst Calls & Verified Technical Trade Signals - fcp.pa.gov.br

Click here to get full coverage on Activity Recap: Is CGON stock a top pick in earnings season - 2025 Year in Review & Fast Exit/Entry Strategy Plans - fcp.pa.gov.br

Activity Recap: Is CGON stock a top pick in earnings season - 2025 Year in Review & Fast Exit/Entry Strategy Plans  fcp.pa.gov.br

Activity Recap: Is CGON stock a top pick in earnings season - 2025 Year in Review & Fast Exit/Entry Strategy Plans - fcp.pa.gov.br

Click here to get full coverage on Guggenheim Initiates CG Oncology (CGON) Coverage with $90 PT, Highlights Bladder Cancer Therapeutic Cretostimogene - Insider Monkey

Guggenheim Initiates CG Oncology (CGON) Coverage with $90 PT, Highlights Bladder Cancer Therapeutic Cretostimogene  Insider Monkey

Guggenheim Initiates CG Oncology (CGON) Coverage with $90 PT, Highlights Bladder Cancer Therapeutic Cretostimogene - Insider Monkey

Click here to get full coverage on Piper Sandler Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $55 - 富途牛牛

Piper Sandler Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $55  富途牛牛

Piper Sandler Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $55 - 富途牛牛

Click here to get full coverage on CG Oncology, Inc. (NASDAQ:CGON) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

CG Oncology, Inc. (NASDAQ:CGON) Given Average Rating of "Moderate Buy" by Brokerages  MarketBeat

CG Oncology, Inc. (NASDAQ:CGON) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Click here to get full coverage on Insider Purchase: Director at $CGON Buys 1,515,151 Shares - Quiver Quantitative

Insider Purchase: Director at $CGON Buys 1,515,151 Shares  Quiver Quantitative

Insider Purchase: Director at $CGON Buys 1,515,151 Shares - Quiver Quantitative

Click here to get full coverage on Is CGON stock trading at a premium valuation - New Guidance & Free Growth Oriented Trading Recommendations - fcp.pa.gov.br

Is CGON stock trading at a premium valuation - New Guidance & Free Growth Oriented Trading Recommendations  fcp.pa.gov.br

Is CGON stock trading at a premium valuation - New Guidance & Free Growth Oriented Trading Recommendations - fcp.pa.gov.br

Click here to get full coverage on TD Asset Management Inc Grows Stock Position in CG Oncology, Inc. $CGON - MarketBeat

TD Asset Management Inc Grows Stock Position in CG Oncology, Inc. $CGON  MarketBeat

TD Asset Management Inc Grows Stock Position in CG Oncology, Inc. $CGON - MarketBeat

Click here to get full coverage on James Mulay Sells 5,903 Shares of CG Oncology (NASDAQ:CGON) Stock - MarketBeat

James Mulay Sells 5,903 Shares of CG Oncology (NASDAQ:CGON) Stock  MarketBeat

James Mulay Sells 5,903 Shares of CG Oncology (NASDAQ:CGON) Stock - MarketBeat

Click here to get full coverage on Can CGON stock resist market sell offs - Quarterly Earnings Summary & Consistent Income Trade Recommendations - fcp.pa.gov.br

Can CGON stock resist market sell offs - Quarterly Earnings Summary & Consistent Income Trade Recommendations  fcp.pa.gov.br

Can CGON stock resist market sell offs - Quarterly Earnings Summary & Consistent Income Trade Recommendations - fcp.pa.gov.br

Click here to get full coverage on What analyst consensus says on CGON stock - Weekly Market Report & High Conviction Investment Ideas - fcp.pa.gov.br

What analyst consensus says on CGON stock - Weekly Market Report & High Conviction Investment Ideas  fcp.pa.gov.br

What analyst consensus says on CGON stock - Weekly Market Report & High Conviction Investment Ideas - fcp.pa.gov.br

Click here to get full coverage on CG Oncology’s Surging Prospects: Buy or Hold? - StocksToTrade

CG Oncology’s Surging Prospects: Buy or Hold?  StocksToTrade

CG Oncology’s Surging Prospects: Buy or Hold? - StocksToTrade

Click here to get full coverage on New Analyst Forecast: $CGON Given $47.0 Price Target - Quiver Quantitative

New Analyst Forecast: $CGON Given $47.0 Price Target  Quiver Quantitative

New Analyst Forecast: $CGON Given $47.0 Price Target - Quiver Quantitative

Click here to get full coverage on CG Oncology (CGON) Is Up 8.6% After Analysts Spotlight Late-Stage Bladder Cancer Therapy Data – Has the Bull Case Changed? - Sahm

CG Oncology (CGON) Is Up 8.6% After Analysts Spotlight Late-Stage Bladder Cancer Therapy Data – Has the Bull Case Changed?  Sahm

CG Oncology (CGON) Is Up 8.6% After Analysts Spotlight Late-Stage Bladder Cancer Therapy Data – Has the Bull Case Changed? - Sahm

Click here to get full coverage on CG Oncology (CGON): Assessing Valuation Following Landmark 24-Month BOND-003 Results for Bladder Cancer Therapy - simplywall.st

CG Oncology (CGON): Assessing Valuation Following Landmark 24-Month BOND-003 Results for Bladder Cancer Therapy  simplywall.st

CG Oncology (CGON): Assessing Valuation Following Landmark 24-Month BOND-003 Results for Bladder Cancer Therapy - simplywall.st

Click here to get full coverage on 41.8% Complete Response: CG Oncology's Breakthrough Bladder Cancer Drug Shows Best-in-Disease Durability - Stock Titan

41.8% Complete Response: CG Oncology's Breakthrough Bladder Cancer Drug Shows Best-in-Disease Durability  Stock Titan

41.8% Complete Response: CG Oncology's Breakthrough Bladder Cancer Drug Shows Best-in-Disease Durability - Stock Titan

Click here to get full coverage on CG Oncology Secures Major Legal Victory: Court Rules No 5% Royalties on Promising Bladder Cancer Drug - Stock Titan

CG Oncology Secures Major Legal Victory: Court Rules No 5% Royalties on Promising Bladder Cancer Drug  Stock Titan

CG Oncology Secures Major Legal Victory: Court Rules No 5% Royalties on Promising Bladder Cancer Drug - Stock Titan

Click here to get full coverage on CG Oncology: Looking Undervalued Heading Toward FDA Submission (Upgrade) (NASDAQ:CGON) - Seeking Alpha

CG Oncology: Looking Undervalued Heading Toward FDA Submission (Upgrade) (NASDAQ:CGON)  Seeking Alpha

CG Oncology: Looking Undervalued Heading Toward FDA Submission (Upgrade) (NASDAQ:CGON) - Seeking Alpha

Click here to get full coverage on First Week of CGON November 21st Options Trading - Nasdaq

First Week of CGON November 21st Options Trading  Nasdaq

First Week of CGON November 21st Options Trading - Nasdaq

Click here to get full coverage on Mulay James sells CG Oncology (CGON) stock worth $884k - Investing.com

Mulay James sells CG Oncology (CGON) stock worth $884k  Investing.com

Mulay James sells CG Oncology (CGON) stock worth $884k - Investing.com

Click here to get full coverage on New Analyst Forecast: $CGON Given 'Buy' Rating - Quiver Quantitative

New Analyst Forecast: $CGON Given 'Buy' Rating  Quiver Quantitative

New Analyst Forecast: $CGON Given 'Buy' Rating - Quiver Quantitative

Click here to get full coverage on Insider Sale: Director at $CGON Sells 3,574 Shares - Quiver Quantitative

Insider Sale: Director at $CGON Sells 3,574 Shares  Quiver Quantitative

Insider Sale: Director at $CGON Sells 3,574 Shares - Quiver Quantitative

Click here to get full coverage on Bladder Cancer Treatment Developer CG Oncology to Present Latest Updates at Global Healthcare Forums - Stock Titan

Bladder Cancer Treatment Developer CG Oncology to Present Latest Updates at Global Healthcare Forums  Stock Titan

Bladder Cancer Treatment Developer CG Oncology to Present Latest Updates at Global Healthcare Forums - Stock Titan

Click here to get full coverage on Largest-Ever Trial: 360 Patients Join CG Oncology's Breakthrough Bladder Cancer Study One Year Early - Stock Titan

Largest-Ever Trial: 360 Patients Join CG Oncology's Breakthrough Bladder Cancer Study One Year Early  Stock Titan

Largest-Ever Trial: 360 Patients Join CG Oncology's Breakthrough Bladder Cancer Study One Year Early - Stock Titan

Click here to get full coverage on Monday 9/15 Insider Buying Report: CGON, NEXT - Nasdaq

Monday 9/15 Insider Buying Report: CGON, NEXT  Nasdaq

Monday 9/15 Insider Buying Report: CGON, NEXT - Nasdaq

Click here to get full coverage on CG Oncology Brings Breakthrough Bladder Cancer Treatment to Goldman Sachs Healthcare Conference - Stock Titan

CG Oncology Brings Breakthrough Bladder Cancer Treatment to Goldman Sachs Healthcare Conference  Stock Titan

CG Oncology Brings Breakthrough Bladder Cancer Treatment to Goldman Sachs Healthcare Conference - Stock Titan

Click here to get full coverage on CG Oncology (CGON): Valuation in Focus After Analyst Coverage and Promising Cretostimogene Phase 3 Results - Sahm

CG Oncology (CGON): Valuation in Focus After Analyst Coverage and Promising Cretostimogene Phase 3 Results  Sahm

CG Oncology (CGON): Valuation in Focus After Analyst Coverage and Promising Cretostimogene Phase 3 Results - Sahm

Click here to get full coverage on How CGON Corporation (CGON) Affects Rotational Strategy Timing - news.stocktradersdaily.com

How CGON Corporation (CGON) Affects Rotational Strategy Timing  news.stocktradersdaily.com

How CGON Corporation (CGON) Affects Rotational Strategy Timing - news.stocktradersdaily.com

Click here to get full coverage on CG Oncology Looks Attractive At Current Prices (Rating Upgrade) (NASDAQ:CGON) - Seeking Alpha

CG Oncology Looks Attractive At Current Prices (Rating Upgrade) (NASDAQ:CGON)  Seeking Alpha

CG Oncology Looks Attractive At Current Prices (Rating Upgrade) (NASDAQ:CGON) - Seeking Alpha

Click here to get full coverage on CG Oncology, Inc. (CGON) reports earnings - qz.com

CG Oncology, Inc. (CGON) reports earnings  qz.com

CGON

Price Chart

Key Statistics

Technicals

About CGON

Latest News

CG Oncology (CGON): Assessing Valuation Following Analyst Coverage and Positive Phase 3 Trial Results - Yahoo Finance

Volatility clustering patterns for CGON - Earnings Miss & Weekly Breakout Stock Alerts - newser.com

Noteworthy Tuesday Option Activity: CGON, DECK, ARQT - Nasdaq

Advanced Charts

Top Gainers

Top Losers